DrAid™ for Liver Segmentation

VinBrain Joint Stock Company · K241543 · 2024-12-06

DrAid™ for Liver Segmentation is an AI-enabled medical device from VinBrain Joint Stock Company, listed by FDA (510(k), K241543) with a decision date of 2024-12-06. Review panel: Radiology.

FDA submission numberK241543
Pathway510(k)
CompanyVinBrain Joint Stock Company
Review panel (specialty)Radiology
FDA decision date2024-12-06
DecisionSubstantially Equivalent
Product codeQIH
ClassificationAutomated Radiological Image Processing Software
Device class2
Regulation number892.2050
Review time (calendar days)189
Applicant countryVN

Official FDA database record · FDA AI-enabled device list

All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.